Rankings
▼
Calendar
CTKB
Cytek Biosciences, Inc.
$553M
FY 2020 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$93M
+60.4% YoY
Gross Profit
$52M
55.7% margin
Operating Income
$14M
14.7% margin
Net Income
$19M
20.9% margin
EPS (Diluted)
$0.02
Cash Flow
Operating Cash Flow
$15M
Free Cash Flow
$14M
Stock-Based Comp.
$611,000
Balance Sheet
Total Assets
$220M
Total Liabilities
$236M
Stockholders' Equity
-$16M
Cash & Equivalents
$165M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$93M
$58M
+60.4%
Gross Profit
$52M
$29M
+80.3%
Operating Income
$14M
-$17M
+179.2%
Net Income
$19M
-$17M
+215.4%
← FY 2019
All Quarters
Q1 2020 →
CTKB FY 2020 Earnings — Cytek Biosciences, Inc. Revenue & Financial Results | Market Cap Arena